FDA has approved Joenja (leniolisib) tablets as the first treatment for activated phosphoinositide 3-kinase delta syndrome in children 4-11 years who weigh at least 27 kg....
Sun safety is always in season. It’s important to protect your skin from sun damage throughout the year, no matter the weather. The FDA continues to...
Your infant’s sensitive skin is vulnerable to serious burns. But sunscreen isn’t the answer. Infants are at greater risk than adults of sunscreen side effects, such...
FDA created the Rare Disease Innovation Hub (the Hub) to serve as a point of collaboration and connectivity between CBER and CDER with the goal of...
FDA compliance programs provide guidance and instructions to FDA staff for obtaining information to help fulfill agency plans in the specified program area.
FDA's Office of Hematology Oncology Products is recruiting Medical Oncologists to serve in the dynamic, highly challenging, and innovative atmosphere of oncology drug development and research.
The following questions and answers provide more information on FDA’s regulatory actions on over-the-counter sunscreen.
Medical Action Industries is correcting epidural kits containing recalled Huons Co. sodium chloride ampules.
International Council on Harmonisation - Joint Safety/Efficacy (Multidisciplinary)
FDA-TRACK: Expanded Access (Compassionate Use) Submission Data
Scan to Read